GCTK
:GlucoTrack Inc *
Snapshot
|
Charting
|
News
|
Options
*
Deficient
:
Issuer Failed to Meet NASDAQ Continued Listing Requirements
$2.55
21.05%
$0.68
NASDAQ
8:14a ET
August 6 '26
E.F. Hutton & Co. Acts as Exclusive Financial Advisor for $5.5 Million Financing for Glucotrack
GlobeNewswire
Last
Change
Exchange
Market data is delayed by at least 15 minutes.
Markets
Portfolio
Symbol Lookup
Latest Story
E.F. Hutton & Co. Acts as Exclusive Financial Advisor for $5.5 Million Financing for Glucotrack
GlobeNewswire
Full Story →
Headline News
E.F. Hutton & Co. Serves as Exclusive Financial Advisor on Strategic Business Combination Between Glucotrack and LÅkahi Therapeutics and Exclusive Placement Agent for Approximately $5.7 Million Convertible Note Financing
1:19p ET July 17 '26
GlobeNewswire
Glucotrack, Inc. and LÅkahi Therapeutics(TM) Announce Strategic Financing Support from E.F. Hutton & Co. in Connection with Their Recently Completed Business Combination and Future Capital Markets Initiatives
8:04a ET July 17 '26
GlobeNewswire
UPDATE - Glucotrack and LÅkahi Therapeutics Complete Strategic Business Combination, Establishing LÅkahi-Controlled Public Platform
4:57p ET July 16 '26
GlobeNewswire
More News →
Day
21.05%
Week
14.43%
Month
53.49%
More Charting →
September 11 '26. Markets Closed.
Last
$2.55
Day change
21.05%
$0.68
Open
$3.06
Gap at open
$0.17
Previous close
$3.23
Trading volume
744,247
10 Day avg vol.
145,195
Shares out.
798.0
K
Market cap.
$2.0
Mil
Trading activity
Above Avg.
Previous data from yesterday, September 10 '26.
Historical Price Performance
3 month
56.00%
6 month
84.96%
1 year
98.39%
2 year
100.00%
Earnings
Previous 12m
-$12.02
Next 12m Estimate
NM
P/E ratio
--
Revenue
0
Mil
Market data provided by
News provided by